7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chinese expert consensus on cone‐beam CT‐guided diagnosis, localization and treatment for pulmonary nodules

      other
      1 , 2 , 3 , 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 17 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 32 , 39 , 1 , 2 , 3 , 40 , 4 , , 1 , 2 , 3 , , the Professional Committee on Interventional Pulmonology of China Association for Promotion of Health Science and Technology
      Thoracic Cancer
      John Wiley & Sons Australia, Ltd
      cone‐beam CT, diagnosis, localization, pulmonary nodule, treatment

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cone‐beam computed tomography (CBCT) system can provide real‐time 3D images and fluoroscopy images of the region of interest during the operation. Some systems can even offer augmented fluoroscopy and puncture guidance. The use of CBCT for interventional pulmonary procedures has grown significantly in recent years, and numerous clinical studies have confirmed the technology's efficacy and safety in the diagnosis, localization, and treatment of pulmonary nodules. In order to optimize and standardize the technical specifications of CBCT and guide its application in clinical practice, the consensus statement has been organized and written in a collaborative effort by the Professional Committee on Interventional Pulmonology of China Association for Promotion of Health Science and Technology.

          Abstract

          CBCT system plays a crucial role in interventional pulmonology procedures. It can help operators identifying the position of interventional tools and lesions, as well as monitoring operation area. These features facilitate accurate and efficient diagnosis, localization, and treatment of pulmonary nodules.

          Related collections

          Most cited references86

          • Record: found
          • Abstract: found
          • Article: not found

          Reduced lung-cancer mortality with low-dose computed tomographic screening.

          (2011)
          The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer. From August 2002 through April 2004, we enrolled 53,454 persons at high risk for lung cancer at 33 U.S. medical centers. Participants were randomly assigned to undergo three annual screenings with either low-dose CT (26,722 participants) or single-view posteroanterior chest radiography (26,732). Data were collected on cases of lung cancer and deaths from lung cancer that occurred through December 31, 2009. The rate of adherence to screening was more than 90%. The rate of positive screening tests was 24.2% with low-dose CT and 6.9% with radiography over all three rounds. A total of 96.4% of the positive screening results in the low-dose CT group and 94.5% in the radiography group were false positive results. The incidence of lung cancer was 645 cases per 100,000 person-years (1060 cancers) in the low-dose CT group, as compared with 572 cases per 100,000 person-years (941 cancers) in the radiography group (rate ratio, 1.13; 95% confidence interval [CI], 1.03 to 1.23). There were 247 deaths from lung cancer per 100,000 person-years in the low-dose CT group and 309 deaths per 100,000 person-years in the radiography group, representing a relative reduction in mortality from lung cancer with low-dose CT screening of 20.0% (95% CI, 6.8 to 26.7; P=0.004). The rate of death from any cause was reduced in the low-dose CT group, as compared with the radiography group, by 6.7% (95% CI, 1.2 to 13.6; P=0.02). Screening with the use of low-dose CT reduces mortality from lung cancer. (Funded by the National Cancer Institute; National Lung Screening Trial ClinicalTrials.gov number, NCT00047385.).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

            NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effective doses in radiology and diagnostic nuclear medicine: a catalog.

              Medical uses of radiation have grown very rapidly over the past decade, and, as of 2007, medical uses represent the largest source of exposure to the U.S. population. Most physicians have difficulty assessing the magnitude of exposure or potential risk. Effective dose provides an approximate indicator of potential detriment from ionizing radiation and should be used as one parameter in evaluating the appropriateness of examinations involving ionizing radiation. The purpose of this review is to provide a compilation of effective doses for radiologic and nuclear medicine procedures. Standard radiographic examinations have average effective doses that vary by over a factor of 1000 (0.01-10 mSv). Computed tomographic examinations tend to be in a more narrow range but have relatively high average effective doses (approximately 2-20 mSv), and average effective doses for interventional procedures usually range from 5-70 mSv. Average effective dose for most nuclear medicine procedures varies between 0.3 and 20 mSv. These doses can be compared with the average annual effective dose from background radiation of about 3 mSv. (c) RSNA, 2008.
                Bookmark

                Author and article information

                Contributors
                3195024@edu.zju.cn
                xkyyjysun@163.com
                Journal
                Thorac Cancer
                Thorac Cancer
                10.1111/(ISSN)1759-7714
                TCA
                Thoracic Cancer
                John Wiley & Sons Australia, Ltd (Melbourne )
                1759-7706
                1759-7714
                09 February 2024
                March 2024
                : 15
                : 7 ( doiID: 10.1111/tca.v15.7 )
                : 582-597
                Affiliations
                [ 1 ] Department of Respiratory Endoscopy, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
                [ 2 ] Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
                [ 3 ] Shanghai Engineering Research Center of Respiratory Endoscopy Shanghai China
                [ 4 ] Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Disease Sir Run Run Shaw Hospital of Zhejiang University Hangzhou China
                [ 5 ] Department of Pulmonary and Critical Care Medicine Second Affiliated Hospital of Harbin Medical University Harbin China
                [ 6 ] Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Medical School Ningbo University Ningbo China
                [ 7 ] Department of Respiration, Changhai Hospital Naval Medical University Shanghai China
                [ 8 ] Department of Pulmonary and Critical Care Medicine, China‐Japan Friendship Hospital Beijing China
                [ 9 ] Department of Respiratory and Critical Care Medicine The First Affiliated Hospital of Soochow University Suzhou China
                [ 10 ] Department of Respiratory and Critical Care Medicine The Second Hospital of Hebei Medical University Shijiazhuang Hebei China
                [ 11 ] Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an China
                [ 12 ] Department of Respiratory Disease The First Affiliated Hospital of Bengbu Medical College Bengbu China
                [ 13 ] Department of Respiratory Medicine, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai China
                [ 14 ] Dept of Respiratory and Critical Care Medicine The First Affiliated Hospital of Chongqing Medical University Chongqing China
                [ 15 ] Department of Respiratory Medicine Affiliated Hospital of Jiangnan University Wuxi China
                [ 16 ] Department of Respiratory Medicine Guizhou Aerospace Hospital Zunyi China
                [ 17 ] Department of Respiratory and Critical Care Medicine West China Hospital of Sichuan University Chengdu China
                [ 18 ] Department of Respiratory and Critical Care Medicine First Affiliated Hospital of Kunming Medical University Kunming China
                [ 19 ] Department of Respiratory Diseases Xi'an International Medical Center Xi'an China
                [ 20 ] Department of Respiratory and Critical Care Medicine Shanxi Medical University Affiliated First Hospital Taiyuan China
                [ 21 ] China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease The First Affiliated Hospital of Guangzhou Medical University Guangzhou China
                [ 22 ] Department of Respiratory and Critical Care Medicine Tianjin Medical University General Hospital Tianjin China
                [ 23 ] Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China
                [ 24 ] Department of Respiratory Medicine Lanzhou University Second Hospital Lanzhou China
                [ 25 ] Department of Respiratory Medicine The First Affiliated Hospital of Zhengzhou University Zhengzhou China
                [ 26 ] Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital Capital Medical University Beijing China
                [ 27 ] Department of Respiratory Centre The Second Affiliated Hospital of Xiamen Medical College Xiamen China
                [ 28 ] Department of Respiratory and Critical Care Medicine Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China
                [ 29 ] Department of Respiratory Medicine, The Second Xiangya Hospital Central South University Changsha China
                [ 30 ] Department of Respiratory and Critical Care Medicine, Shanghai East Hospital Tongji University School of Medicine Shanghai China
                [ 31 ] Department of Respiratory and Critical Care Medicine The First Affiliated Hospital of Nanchang University Nanchang China
                [ 32 ] Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University Zhengzhou China
                [ 33 ] Department of Respiratory Medicine Xinjiang Chest Hospital Wulumuqi China
                [ 34 ] Department of Tuberculosis The Third People's Hospital of Shenzhen Shenzhen China
                [ 35 ] Department of Pulmonary and Critical Care Medicine Guizhou Provincial People's Hospital Guiyang China
                [ 36 ] Department of Respiratory and Critical Care Medicine, Yantai Yuhuangding Hospital Affiliated with the Medical College of Qingdao Yantai China
                [ 37 ] Department of Respiratory Medicine, Emergency General Hospital Beijing China
                [ 38 ] Pulmonary Intervention Department Anhui Chest Hospital Hefei China
                [ 39 ] Department of Respiratory Medicine, Nanjing Drum Tower Hospital Nanjing University Medical School Nanjing China
                [ 40 ] Department of Respiratory and Critical Care Medicine, Sichuan Provincial People's Hospital University of Electronic Science and Technology of China Chengdu China
                Author notes
                [*] [* ] Correspondence

                Jiayuan Sun, Department of Respiratory Endoscopy, Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, No. 241 West Huaihai Road, Shanghai 200030, China.

                Email: xkyyjysun@ 123456163.com

                Enguo Chen, Department of Pulmonary and Critical Care Medicine, Regional medical center for National institute of respiratory disease, Sir Run Run Shaw hospital of Zhejiang University, No. 3, Qingchun East Road, Hangzhou, 310016, Zhejiang, China.

                Email: 3195024@ 123456edu.zju.cn

                Author information
                https://orcid.org/0000-0002-9451-6520
                https://orcid.org/0000-0001-7716-4036
                https://orcid.org/0000-0002-4857-2265
                https://orcid.org/0000-0003-2487-2244
                https://orcid.org/0000-0001-6337-1173
                https://orcid.org/0000-0002-1008-4872
                https://orcid.org/0000-0003-3158-3256
                Article
                TCA15222
                10.1111/1759-7714.15222
                10912555
                38337087
                005cac97-2253-46ff-a470-43e06dba4b6e
                © 2024 The Authors. Thoracic Cancer published by John Wiley & Sons Australia, Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 02 January 2024
                : 07 January 2024
                Page count
                Figures: 1, Tables: 0, Pages: 16, Words: 13728
                Funding
                Funded by: National Multi‐disciplinary Treatment Project for Major Diseases
                Award ID: 2020NMDTP
                Funded by: Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support
                Award ID: 20181815
                Categories
                Clinical Guideline
                Clinical Guideline
                Custom metadata
                2.0
                March 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.9 mode:remove_FC converted:05.03.2024

                cone‐beam ct,diagnosis,localization,pulmonary nodule,treatment

                Comments

                Comment on this article